2018
DOI: 10.1016/j.aanat.2018.01.011
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of peri-implant bone osteogenic activity induced by a peptidomimetic functionalization of titanium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 35 publications
1
5
0
Order By: Relevance
“…Ref. [ 36 ]). In the context of BMP-2-functionalised Ti6Al4V, Kashigawi and colleagues [ 33 ] modified this growth factor with a peptide motif (RKLPDA) known to bond electrostatically to Ti6Al4V [ 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…Ref. [ 36 ]). In the context of BMP-2-functionalised Ti6Al4V, Kashigawi and colleagues [ 33 ] modified this growth factor with a peptide motif (RKLPDA) known to bond electrostatically to Ti6Al4V [ 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…Although in vivo experiment reported a short time (∼15 d) for adhesive peptides to carry out the endosseous biological activity [21], in the present research study we decided to extend the in vivo experimental time (∼45-60 d) to maximize scaffold mineralization. Indeed, it has been reported that, to obtain a good degree of mineralization in the subcutaneous area time ranging from weeks to months is required [44].…”
Section: In Vivo Assaysmentioning
confidence: 99%
“…The importance to assure a stable and stereooriented peptide anchoring on the scaffold [17][18][19], was taken into consideration [16,20,21].…”
Section: Introductionmentioning
confidence: 99%
“…With the aim to confer stability to the HVP peptide, the retro-inverted analog DHVP and its dimeric sequence D2HVP were designed and synthesized. Moreover, we investigated the ability of DHVP and D2HVP to maintain bioactivities comparable to those of native sequences including the analysis of cytotoxicity and resistance to proteolytic degradation [16,29]. Previous results demonstrated that the dimeric analog D2HVP is able to greatly increase cell adhesion, proliferation, gene expression, and mineralization in vitro when compared both to shorter HVP and DHVP peptides [16,30]: this improved bioactivity of the dimeric peptide in respect to DHVP could be inferred to increased ionic interactions with cellular GAGs or to a greater distance of the bioactive sequence from the implant surface (the first nine amino acids acting as a spacer), resulting in a better exposure of the adhesive sequence to the osteoblasts.…”
Section: Introductionmentioning
confidence: 99%